Literature DB >> 16143103

Molecular determinants of crosstalk between nuclear receptors and toll-like receptors.

Sumito Ogawa1, Jean Lozach, Chris Benner, Gabriel Pascual, Rajendra K Tangirala, Stefan Westin, Alexander Hoffmann, Shankar Subramaniam, Michael David, Michael G Rosenfeld, Christopher K Glass.   

Abstract

Nuclear receptors (NRs) repress transcriptional responses to diverse signaling pathways as an essential aspect of their biological activities, but mechanisms determining the specificity and functional consequences of transrepression remain poorly understood. Here, we report signal- and gene-specific repression of transcriptional responses initiated by engagement of toll-like receptors (TLR) 3, 4, and 9 in macrophages. The glucocorticoid receptor (GR) represses a large set of functionally related inflammatory response genes by disrupting p65/interferon regulatory factor (IRF) complexes required for TLR4- or TLR9-dependent, but not TLR3-dependent, transcriptional activation. This mechanism requires signaling through MyD88 and enables the GR to differentially regulate pathogen-specific programs of gene expression. PPARgamma and LXRs repress overlapping transcriptional targets by p65/IRF3-independent mechanisms and cooperate with the GR to synergistically transrepress distinct subsets of TLR-responsive genes. These findings reveal combinatorial control of homeostasis and immune responses by nuclear receptors and suggest new approaches for treatment of inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16143103      PMCID: PMC1430687          DOI: 10.1016/j.cell.2005.06.029

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  81 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Creating the gene ontology resource: design and implementation.

Authors: 
Journal:  Genome Res       Date:  2001-08       Impact factor: 9.043

Review 3.  Vitamin D analogs: mechanism of action and therapeutic applications.

Authors:  S Nagpal; J Lu; M F Boehm
Journal:  Curr Med Chem       Date:  2001-11       Impact factor: 4.530

4.  The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain.

Authors:  R M Nissen; K R Yamamoto
Journal:  Genes Dev       Date:  2000-09-15       Impact factor: 11.361

5.  Impaired estrogen sensitivity in bone by inhibiting both estrogen receptor alpha and beta pathways.

Authors:  S Ogawa; M Fujita; Y Ishii; H Tsurukami; M Hirabayashi; K Ikeda; A Orimo; T Hosoi; M Ueda; T Nakamura; Y Ouchi; M Muramatsu; S Inoue
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

6.  Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones.

Authors:  I Rogatsky; K A Zarember; K R Yamamoto
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

7.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

8.  A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

Authors:  A Chawla; W A Boisvert; C H Lee; B A Laffitte; Y Barak; S B Joseph; D Liao; L Nagy; P A Edwards; L K Curtiss; R M Evans; P Tontonoz
Journal:  Mol Cell       Date:  2001-01       Impact factor: 17.970

9.  Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3.

Authors:  L Alexopoulou; A C Holt; R Medzhitov; R A Flavell
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

10.  Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6.

Authors:  H Häcker; R M Vabulas; O Takeuchi; K Hoshino; S Akira; H Wagner
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

View more
  247 in total

1.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation.

Authors:  Alessia Perino; Thijs Willem Hendrik Pols; Mitsunori Nomura; Sokrates Stein; Roberto Pellicciari; Kristina Schoonjans
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  Coordinate regulation of neutrophil homeostasis by liver X receptors in mice.

Authors:  Cynthia Hong; Yoko Kidani; Noelia A-Gonzalez; Tram Phung; Ayaka Ito; Xin Rong; Katrin Ericson; Hanna Mikkola; Simon W Beaven; Lloyd S Miller; Wen-Hai Shao; Philip L Cohen; Antonio Castrillo; Peter Tontonoz; Steven J Bensinger
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

4.  PPARs and lipid ligands in inflammation and metabolism.

Authors:  Gregory S Harmon; Michael T Lam; Christopher K Glass
Journal:  Chem Rev       Date:  2011-10-12       Impact factor: 60.622

Review 5.  Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells.

Authors:  Christopher K Glass; Kaoru Saijo
Journal:  Nat Rev Immunol       Date:  2010-05       Impact factor: 53.106

6.  Meeting report: nuclear receptors: transcription factors and drug targets connecting basic research with translational medicine.

Authors:  Jan Tuckermann; William Bourguet; Susanne Mandrup
Journal:  Mol Endocrinol       Date:  2010-06-02

7.  High-density lipoprotein suppresses the type I interferon response, a family of potent antiviral immunoregulators, in macrophages challenged with lipopolysaccharide.

Authors:  Masashi Suzuki; David K Pritchard; Lev Becker; Andrew N Hoofnagle; Natsuko Tanimura; Theo K Bammler; Richard P Beyer; Roger Bumgarner; Tomas Vaisar; Maria C de Beer; Frederick C de Beer; Kensuke Miyake; John F Oram; Jay W Heinecke
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

8.  FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages.

Authors:  Wuqiang Fan; Hidetaka Morinaga; Jane J Kim; Eunju Bae; Nathanael J Spann; Sven Heinz; Christopher K Glass; Jerrold M Olefsky
Journal:  EMBO J       Date:  2010-11-02       Impact factor: 11.598

Review 9.  Circadian CLOCK-mediated regulation of target-tissue sensitivity to glucocorticoids: implications for cardiometabolic diseases.

Authors:  Tomoshige Kino; George P Chrousos
Journal:  Endocr Dev       Date:  2010-12-16

10.  Toll-like receptor 4 enhancement of non-NMDA synaptic currents increases dentate excitability after brain injury.

Authors:  Ying Li; Akshata A Korgaonkar; Bogumila Swietek; Jianfeng Wang; Fatima S Elgammal; Stella Elkabes; Vijayalakshmi Santhakumar
Journal:  Neurobiol Dis       Date:  2014-12-08       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.